March 20, 2018 / 12:38 AM / 9 months ago

BRIEF-Helix Biopharma Reports Q2 Loss Per Share of C$0.03

1 Min Read

March 19 (Reuters) - Helix Biopharma Corp:

* . ANNOUNCES FISCAL SECOND QUARTER 2018 RESULTS

* Q2 LOSS PER SHARE C$0.03 Source text for Eikon: Further company coverage:

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below